Sgarbanti M - Search Results

1

Activation of Latent HIV-1 T Cell Reservoirs with a Combination of Innate Immune and Epigenetic Regulators.

Palermo E, Acchioni C, Di Carlo D, Zevini A, Muscolini M, Ferrari M, Castiello L, Virtuoso S, Borsetti A, Antonelli G, Turriziani O, Sgarbanti M, Hiscott J. Palermo E, et al. Among authors: sgarbanti m. J Virol. 2019 Oct 15;93(21):e01194-19. doi: 10.1128/JVI.01194-19. Print 2019 Nov 1. J Virol. 2019. PMID: 31413127 Free PMC article.

2

IRF regulation of HIV-1 long terminal repeat activity.

Battistini A, Marsili G, Sgarbanti M, Ensoli B, Hiscott J. Battistini A, et al. Among authors: sgarbanti m. J Interferon Cytokine Res. 2002 Jan;22(1):27-37. doi: 10.1089/107999002753452638. J Interferon Cytokine Res. 2002. PMID: 11846973 Review.

3

Modulation of human immunodeficiency virus 1 replication by interferon regulatory factors.

Sgarbanti M, Borsetti A, Moscufo N, Bellocchi MC, Ridolfi B, Nappi F, Marsili G, Marziali G, Coccia EM, Ensoli B, Battistini A. Sgarbanti M, et al. J Exp Med. 2002 May 20;195(10):1359-70. doi: 10.1084/jem.20010753. J Exp Med. 2002. PMID: 12021315 Free PMC article.

4

Disruption of the B-cell specific transcriptional program in HHV-8 associated primary effusion lymphoma cell lines.

Arguello M, Sgarbanti M, Hernandez E, Mamane Y, Sharma S, Servant M, Lin R, Hiscott J. Arguello M, et al. Among authors: sgarbanti m. Oncogene. 2003 Feb 20;22(7):964-73. doi: 10.1038/sj.onc.1206270. Oncogene. 2003. PMID: 12592383

5

On the role of interferon regulatory factors in HIV-1 replication.

Marsili G, Borsetti A, Sgarbanti M, Remoli AL, Ridolfi B, Stellacci E, Ensoli B, Battistini A. Marsili G, et al. Among authors: sgarbanti m. Ann N Y Acad Sci. 2003 Dec;1010:29-42. doi: 10.1196/annals.1299.005. Ann N Y Acad Sci. 2003. PMID: 15033691 Review.

6

Analysis of the signal transduction pathway leading to human immunodeficiency virus-1-induced interferon regulatory factor-1 upregulation.

Sgarbanti M, Marsili G, Remoli AL, Ridolfi B, Stellacci E, Borsetti A, Ensoli B, Battistini A. Sgarbanti M, et al. Ann N Y Acad Sci. 2004 Dec;1030:187-95. doi: 10.1196/annals.1329.024. Ann N Y Acad Sci. 2004. PMID: 15659797

7

IRF-1 is required for full NF-kappaB transcriptional activity at the human immunodeficiency virus type 1 long terminal repeat enhancer.

Sgarbanti M, Remoli AL, Marsili G, Ridolfi B, Borsetti A, Perrotti E, Orsatti R, Ilari R, Sernicola L, Stellacci E, Ensoli B, Battistini A. Sgarbanti M, et al. J Virol. 2008 Apr;82(7):3632-41. doi: 10.1128/JVI.00599-07. Epub 2008 Jan 23. J Virol. 2008. PMID: 18216101 Free PMC article.

8

Generation of a human immunodeficiency virus type 1 chronically infected monkey B cell line expressing low levels of endogenous TRIM5alpha.

Ridolfi B, Catone S, Sgarbanti M, Sernicola L, Battistini A, Parolin C, Titti F, Borsetti A. Ridolfi B, et al. Among authors: sgarbanti m. J Cell Physiol. 2009 Dec;221(3):760-5. doi: 10.1002/jcp.21914. J Cell Physiol. 2009. PMID: 19746418

9

The development of immune-modulating compounds to disrupt HIV latency.

Remoli AL, Marsili G, Battistini A, Sgarbanti M. Remoli AL, et al. Among authors: sgarbanti m. Cytokine Growth Factor Rev. 2012 Aug-Oct;23(4-5):159-72. doi: 10.1016/j.cytogfr.2012.05.003. Epub 2012 Jul 4. Cytokine Growth Factor Rev. 2012. PMID: 22766356 Review.

10

Therapeutics for HIV-1 reactivation from latency.

Sgarbanti M, Battistini A. Sgarbanti M, et al. Curr Opin Virol. 2013 Aug;3(4):394-401. doi: 10.1016/j.coviro.2013.06.001. Epub 2013 Jun 28. Curr Opin Virol. 2013. PMID: 23810462 Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

44 results

Search Page